CD8A and clear cell renal carcinoma: Another study by them demonstrated that the administration of anti-VISTA treatment led to a significant increase in the percentage of granzyme B+ Perforin+ CD8+ T cells in most patients with clear cell renal cell carcinoma (62, 68).